Effectiveness and safety of pembrolizumab for patients with advanced non-small cell lung cancer in real-world studies and randomized controlled trials: A systematic review and meta-analysis

Nav

General Info

Geography

Global

Coverage type

Global

Time period covered

01/2017 - 12/2021

Data type

Scientific literature

Keywords

Trachea, bronchus, and lung cancers

Citation

Authors

Yang B, Wang B, Chen Y, Wan N, Xie F, Yang N, Lu L, Xiao W, Yuan J, Li J, Xie B, Ji B

Journal

Front Oncol

Volume

Issue

1044327

Pages

1044327

Publication year

2023

Suggested citation

Yang B, Wang B, Chen Y, Wan N, Xie F, Yang N, Lu L, Xiao W, Yuan J, Li J, Xie B, Ji B. Effectiveness and safety of pembrolizumab for patients with advanced non-small cell lung cancer in real-world studies and randomized controlled trials: A systematic review and meta-analysis. Front Oncol. 2023; 13(1044327): 1044327.

DOI

103389fonc20231044327

PMID

36824127

GHDx Entry last modified on: Mar 25, 2025

Header sites

Search form

Main menu

Effectiveness and safety of pembrolizumab for patients with advanced non-small cell lung cancer in real-world studies and randomized controlled trials: A systematic review and meta-analysis

Nav